21 – 30 of 72
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer
- Contribution to journal › Article
-
Mark
Outcomes Following Exenteration for Gynecological Neoplasms
(2021) p.265-282
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2020
-
Mark
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
- Contribution to journal › Article
-
Mark
SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery
- Contribution to journal › Article
-
Mark
High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer
- Contribution to journal › Article
-
Mark
Ovarian cancer subtypes and survival in relation to three comprehensive imaging parameters
- Contribution to journal › Article
- 2019
-
Mark
Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method
- Contribution to journal › Article
-
Mark
Can we extend the indication for sentinel node biopsy in vulvar cancer? A nationwide feasibility study from Sweden
(2019) In International Journal of Gynecological Cancer
- Contribution to journal › Article
-
Mark
Albumin infusion rate and plasma volume expansion : A randomized clinical trial in postoperative patients after major surgery
- Contribution to journal › Article
- 2018
-
Mark
Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function
- Contribution to journal › Article
